2.5 ml semaglutide 2mL Vial – Le Beau Visage Medical Spa Sematrinity 2mg Pre-filled Pen| Advanced

J Physiol Pharmacol 2007

Noom provides support at every stage, from coaching to meal tracking and more

Eating less going to the gym and getting sleep

Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy

Answer a few quick questions about yourself, and we'll guide you to the most suitable treatment option